GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors

By sjmartinez • September 1, 2024

Patel R, Wadid M, Makwana B, Kumar A, Khadke S, Bhatti A, Banker A, Husami Z, Labib S, Venesy D, Fonarow G, Kosiborod M, Al-Kindi S, Bhatt DL, Dani S, Nohria A, Butler J, Ganatra S. GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors. JACC Heart Fail. 2024 Aug 16:S2213-1779(24)00561-4. doi: 10.1016/j.jchf.2024.07.006. Epub ahead of print. PMID: 39207323.

Tags: Cardiology/Epi, GLP-1 receptor agonists, Heart failure with preserved ejection fraction, Obesity, overweight, Publications, SGLT2is

Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapy

Li YR, Nan H, Liu Z, Fang Y, Zhu Y, Lyu Z, Shao Z, Zhu E, Zhang B, Yang Y, Shen X, Chen Y, Hsiai[...]

Pharmacologic Management of Ventricular Arrhythmias: Targeting Nicotinic Signaling Mechanisms

Ahluwalia N, Hanna P, Shivkumar K. Pharmacologic Management of Ventricular Arrhythmias: Targeting Nicotinic Signaling Mechanisms. J Am Coll Cardiol. 2026 Mar 10:S0735-1097(26)05234-4. doi: 10.1016/j.jacc.2026.01.084. Epub[...]

Echocardiography in HIV Disease

Durstenfeld MS, Kizer JR. Echocardiography in HIV Disease. Curr Cardiol Rep. 2026 Mar 18;28(1):34. doi: 10.1007/s11886-026-02353-9. PMID: 41848979.